Public disclosure of inside information according to article 17 MAR
Leverkusen (pta022/01.08.2025/12:05) - "Following the restructuring of its cooperation with Biofrontera Inc., Biofrontera AG forecasts revenues of €17 million to €20 million for the 2025 financial year. Biofrontera AG subsequently forecasts EBITDA of €1.5 million to €3.5 million for 2025."
(end)
emitter: Biofrontera AG
address: Hemmelrather Weg 201, 51377 Leverkusen
country: Germany
contact person: Investor Relations
phone: +49 (0) 214 87 63 20
e-mail: ir@biofrontera.com
website: www.biofrontera.com
ISIN(s): DE000A4BGGM7 (share)
stock exchanges: regulated market in Dusseldorf, Frankfurt; free market in Munich, free market in Stuttgart; open market in Berlin, Tradegate